QURE 8-K 2026-11-04

uniQure N.V. (QURE) 8-K dated 2026-11-04 — accession 0001104659-26-122362.

uniQure N.V. (QURE) is a biotechnology company listed on NASDAQ.

uniQure N.V. filed a 8-K on 2026-11-04. Accession 0001104659-26-122362.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported QURE revenue for 2025-12-31 was $16.1M. Net income was -$199.0M. Revenue was down 40.6% from 2024-12-31 to 2025-12-31. QURE currently screens at market cap $3.04B.

Not investment advice. The QURE SEC hub lists recent forms. The stock page is the research view.